Physician sex and outcomes among hospitalized patients
Jerath A, Wallis CJD, Heybati K, Zhang B, Ko DT, Fang J, Saskin R, Satkunasivam R, Mamas MA, Yu AYX, Detsky AS, Coburn N, Zipursky JS. JAMA Netw Open. 2026; 9(11): e2641487.
Aims — Cannabis use may increase the risk of self-harm, but whether legalization of cannabis is associated with changes in self-harm is unknown. We examined changes in cannabis-involvement in emergency department (ED) visits for self-harm after the liberalization of medical and legalization of non-medical cannabis in Canada.
Methods — This repeated cross-sectional study used health administrative data to identify all ED visits for self-harm in individuals aged ten and older between January 2010 and December 2021. We identified self-harm ED visits with a co-diagnosis of cannabis (main exposure) or alcohol (control condition) and examined changes in rates of visits over four distinct policy periods (pre-legalization, medical liberalization, non-medical legalization with restrictions, and non-medical commercialization/COVID-19) using Poisson models.
Results — The study included 158,912 individuals with one or more self-harm ED visits, of which 7810 (4.9 %) individuals had a co-diagnosis of cannabis use and 24,761 (15.6 %) had a co-diagnosis of alcohol use. Between 2010 and 2021, the annual rate of ED visits for self-harm injuries involving cannabis per 100,000 individuals increased by 90.1 % (3.6 in 2010 to 6.9 in 2021 per 100,000 individuals), while the annual rate of self-harm injuries involving alcohol decreased by 17.3 % (168.1 in 2010 to 153.1 in 2021 per 100,000 individuals). The entire increase in visits relative to pre-legalization occurred after medical liberalization (seasonally adjusted Risk Ratio [asRR] 1.71 95 % CI 1.09–1.15) with no further increases during the legalization with restrictions (asRR 1.77 95%CI 1.62–1.93) or commercialization/COVID-19 periods (asRR 1.63 95%CI 1.50–176).
Conclusions — Cannabis-involvement in self-harm ED visits almost doubled over 12 years and may have accelerated after medical cannabis liberalization. While the results cannot determine whether cannabis is increasingly causing self-harm ED visits or whether cannabis is increasingly being used by individuals at high risk of self-harm, greater detection for cannabis use in this population and intervention may be indicated.
Myran DT, Gaudreault A, Pugliese M, Tanuseputro P, Saunders N. J Affect Disord. 2024; Feb 1 [Epub ahead of print].
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.